22h agoInvestor Villi Iltchev relays anecdote that administrative cuts have severely delayed the FDA vaccine approval pipelineA professor seeking vaccine approval originally reported the bottlenecksSentimentSentimentPos0%Neg100%Users criticized FDA vaccine approval changes as worsening an already messy process with contradictory feedback, excessive delays, and administrative bottlenecks that hurt biotech timelines.4 comments with sentiment. View comments.